Article

Sport-tinted lens filters blue light, sharpens vision

Rochester, NY–Bausch & Lomb plans to launch its Nike Maxsight (polymacon) sport-tinted contact lens later this summer now that the FDA has cleared the lens for market distribution.

The soft contact lens corrects refractive myopia and hyperopia while filtering specific wavelengths of light to enhance sports settings. The lensreduces distracting sun glare during outdoor activities, making a ball or other objects more visible than with the naked eye, Bausch & Lomb claims. The company said the patented Light Architecture optics filter most of the blue light and manipulate the remaining colors of the spectrum to enhance visibility of the ball. Wearers will not have to contend with the difficulties associated with spectacles–fogged or scratched lenses, sweating, or a nosepiece or frame that limits vision.

Bausch & Lomb said it will manufacture the lens and market it to eye-care professionals, while Nike–which had solicited Bausch & Lomb 3 years ago as a partner in the lens–will handle consumer marketing.

Although the lens is indicated for daily wear, the company recommends wearing it for shorter periods, and replacing them after 30 days.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.